Citation Impact
Citing Papers
Human Hypertension Caused by Mutations in WNK Kinases
2001 StandoutScience
PIEZOs mediate neuronal sensing of blood pressure and the baroreceptor reflex
2018 StandoutScienceNobel
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
No health without mental health
2007 Standout
Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology
2019
Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: Emerging insights for evolving paradigms
2000
Rosuvastatin in the management of hyperlipidemia
2004
The safety of statins in clinical practice
2007
Molecular genetics of human hypertension
1998
Molecular genetics of human hypertension
2000
Perceived discrimination and health: A meta-analytic review.
2009 Standout
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Isolates and their potential use in complex gene mapping efforts
2004
Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls
2000
Multiplexed SNP genotyping using the QbeadTM system: a quantum dot-encoded microsphere-based assay
2003
Association of Cholesteryl Ester Transfer Protein Genotypes With CETP Mass and Activity, Lipid Levels, and Coronary Risk
2008
The metabolic syndrome
2010 Standout
Molecular Mechanisms of Human Hypertension
2001 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals
2005
Exercise Standards for Testing and Training
2013 Standout
Sympathetic activation and contribution of genetic factors in hypertension with neurovascular compression of the rostral ventrolateral medulla
1999
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Rosuvastatin for the Treatment of Hypercholesterolemia
2005
Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity
2002
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
2009 Standout
A New Locus on Chromosome 12p13.3 for Pseudohypoaldosteronism Type II, an Autosomal Dominant Form of Hypertension
2000
The right ventricle in pulmonary hypertension
2005
Quantum dot bioconjugates for imaging, labelling and sensing
2005 Standout
The metabolic syndrome
2005 Standout
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Non-alcoholic fatty liver disease
2021 Standout
Williams–Beuren Syndrome
2010 Standout
Graves' Ophthalmopathy
2010 Standout
The development of allergic inflammation
2008 StandoutNature
Stroke
2008 Standout
Diabetes and Atherosclerosis
2002 Standout
Mast Cell Proteases
2007
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Fibulin-5/DANCE is essential for elastogenesis in vivo
2002 StandoutNatureNobel
The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease
2006
Congenital supravalvar aortic stenosis: a simple lesion?
2001
Trigeminal neuralgia: Pathology and pathogenesis
2001 Standout
Genetic disorders of the elastic fiber system
2000
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic Stenosis
2005 Standout
Haplotype analysis of the PPARγ Pro12Ala and C1431T variants reveals opposing associations with body weight
2002
Variance component model to account for sample structure in genome-wide association studies
2010 Standout
Genetic bottlenecks, perceived racism, and hypertension risk among African Americans and first-generation African immigrants
2001
Atherosclerosis
2000 StandoutNature
Common Genetic Vulnerability to Depressive Symptoms and Coronary Artery Disease: A Review and Development of Candidate Genes Related to Inflammation and Serotonin
2006
New Target Regions for Human Hypertension via Comparative Genomics
2000
Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans
2009 StandoutNobel
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Chronic Kidney Disease
2016 Standout
Roles of PPARs in health and disease
2000 StandoutNature
The kinase Grk2 regulates Nedd4/Nedd4-2-dependent control of epithelial Na + channels
2004 StandoutNobel
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
2000 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Evidence for Association and Genetic Linkage of the Angiotensin-Converting Enzyme Locus With Hypertension and Blood Pressure in Men but Not Women in the Framingham Heart Study
1998
Abnormal Vascular Function and Hypertension in Mice Deficient in Estrogen Receptor β
2002 StandoutScienceNobel
Four Faces of Baroreflex Failure
2002
Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene
2004 StandoutNobel
Genetic Polymorphism in MDR-1: A Tool for Examining Allelic Expression in Normal Cells, Unselected and Drug-Selected Cell Lines, and Human Tumors
1998
Quantum Dot-Based Multiplexed Fluorescence Resonance Energy Transfer
2005 StandoutNobel
Angiotensin-Converting Enzyme Gene Polymorphisms and Prognosis in Chronic Thromboembolic Pulmonary Hypertension
2006
Genetic Analysis of Inherited Hypertension in the Rat
2000
Angiotensin-Converting Enzyme Gene and Atherosclerosis
1997 StandoutNobel
Modifier genes for hypertrophic cardiomyopathy
2002
A Novel Form of Short QT Syndrome (SQT3) Is Caused by a Mutation in the KCNJ2 Gene
2005
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
In-Situ Encapsulation of Quantum Dots into Polymer Microspheres
2006 StandoutNobel
Impact of Two Common Polymorphisms in the PPARγ Gene on Glucose Tolerance and Plasma Insulin Profiles in Monozygotic and Dizygotic Twins
2003
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Women Have Lower Tonic Autonomic Support of Arterial Blood Pressure and Less Effective Baroreflex Buffering Than Men
2005
Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.
1994
Apolipoproteins B, (a), and E Accumulate in the Morphologically Early Lesion of ‘Degenerative’ Valvular Aortic Stenosis
1996 Standout
Seven Lessons From Two Candidate Genes in Human Essential Hypertension
1999
Epithelial Sodium Channel and the Control of Sodium Balance: Interaction Between Genetic and Environmental Factors
2002
Serum- and Glucocorticoid-Regulated Kinase (SGK1) Gene and Blood Pressure
2002
Regulation and Physiological Roles of Serum- and Glucocorticoid-Induced Protein Kinase Isoforms
2001
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Vitamin A is linked to the expression of the AI-CIII-AIV gene cluster in familial combined hyperlipidemia
1999
A systematic review and economic evaluation of statins for the prevention of coronary events
2007
Global Burden of Cardiovascular Diseases
2001 Standout
Peroxisome Proliferator-Activated Receptor-γ Calls for Activation in Moderation: Lessons from Genetics and Pharmacology
2004
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
2012 Standout
M235T angiotensinogen gene polymorphism and cardiovascular renal risk
1999
Fluorescence Resonance Energy Transfer Between Quantum Dot Donors and Dye-Labeled Protein Acceptors
2003 StandoutNobel
Works of Herbert Schuster being referenced
Oligonucleotide ligation assay (OLA) for the diagnosis of familial hypercholesterolemia
1996
Effects of switching statins on achievement of lipid goals: measuring effective reductions in cholesterol using rosuvastatin therapy (MERCURY I) study
2004
Allele-specific and asymmetric polymerase chain reaction amplification in combination: A one step polymerase chain reaction protocol for rapid diagnosis of familial defective apolipoprotein B-100
1992
Support for linkage of familial combined hyperlipidemia to chromosome 1q21–q23 in Chinese and German families
2000
A region on chromosome 3 is linked to dizygotic twinning
2000
Investigating cardiovascular risk reduction – the Rosuvastatin GALAXY Programme™
2004
Association between genetic variation at the APO AI‐CIII‐AIV gene cluster and familial combined hyperlipidaemia
1994
Quantitative Trait Loci for Blood Pressure Exist Near the IGF-1, the Liddle Syndrome, the Angiotensin II-Receptor Gene and the Renin Loci in Man
1999
A new mutation in the elastin gene causing supravalvular aortic stenosis
1999
Severe autosomal dominant hypertension and brachydactyly in a unique Turkish kindred maps to human chromosome 12
1996
Rosuvastatin – A Highly Effective New 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor: Review of Clinical Trial Data at 10–40 mg Doses in Dyslipidemic Patients
2003
Single Nucleotide Polymorphism Haplotypes in the Cholesteryl-Ester Transfer Protein (CETP) Gene and Lipid Phenotypes
2002
Angiotensin-Converting Enzyme and Heart Chymase gene Polymorphisms in Hypertrophic Cardiomyopathy**This study was supported by a grant-in-aid from the Bundesministerium für Bildung und Forschung and the European commission grant (ERBCHBGCT 940725.
1996
Relation of lipoprotein(a) to coronary heart disease and duplexsonographic findings of the carotid arteries in heterozygous familial hypercholesterolemia
1993
An angiotensin-converting enzyme gene variant is associated with acute myocardial infarction in women but not in men
1995
QT Interval Is Linked to 2 Long-QT Syndrome Loci in Normal Subjects
1999
Heritability Analysis of Lipids and Three Gene Loci in Twins Link the Macrophage Scavenger Receptor to HDL Cholesterol Concentrations
1997
Neurovascular Compression at the Ventrolateral Medulla in Autosomal Dominant Hypertension and Brachydactyly
1997
Angiotensin-Converting Enzyme and Angiotensinogen Gene Polymorphisms, Plasma Levels, Cardiac Dimensions A Twin Study
1997
Linkage but lack of association for blood pressure and the α-adducin locus in normotensive twins
1999
Autosomal Dominant Hypertension and Brachydactyly in a Turkish Kindred Resembles Essential Hypertension
1996
β-2 Adrenergic Receptor Gene Variations, Blood Pressure, and Heart Size in Normal Twins
2000
Severely Impaired Baroreflex-Buffering in Patients With Monogenic Hypertension and Neurovascular Contact
2000
Peroxisome Proliferator–Activated Receptor γ Gene Locus Is Related to Body Mass Index and Lipid Values in Healthy Nonobese Subjects
1999
Evaluation of the Angiotensinogen Locus in Human Essential Hypertension
1998
Elective extracranial-intracranial arterial bypass in the treatment of inoperable giant aneurysms of the internal carotid artery
1980
β‐2 adrenergic receptor gene variations and blood pressure under stress in normal twins
2001
Treasure your exceptions
1995